MarketScreener Homepage > Equities > Swiss Exchange > Lonza Group AG LONN CH0013841017

Report

Real-time Estimate CHI-X - 02/26 11:20:00 am
575.2	CHF		-1.47%

02/24

LONZA : is recognised by Ethisphere as One of the World's Most Ethical Companies 2021

02/23

LONZA : is recognised by Ethisphere ® as One of the World's Most Ethical Companies 2021

02/16

LONZA : Expands Solid Form Selection Services at US Site

Summary

Quotes 5-day view Delayed Quote.

Delayed Swiss Exchange

02/22/2021	02/23/2021	02/24/2021	02/25/2021	02/26/2021	Date
591.2(c)	585.2(c)	592.4(c)	583.8(c)	573.8	Last
178 611	310 483	215 616	169 127	249 448	Volume
-1.60%	-1.01%	+1.23%	-1.45%	-1.71%	Change

More quotes

Financials

Sales 2020	6 161 M 6 800 M 6 800 M
Net income 2020	844 M 932 M 932 M
Net Debt 2020	2 851 M 3 146 M 3 146 M
P/E ratio 2020	50,5x
Yield 2020	0,50%

Sales 2021	4 983 M 5 500 M 5 500 M
Net income 2021	1 073 M 1 184 M 1 184 M
Net Debt 2021	1 790 M 1 976 M 1 976 M
P/E ratio 2021	41,0x
Yield 2021	0,54%

Capitalization	43 370 M 47 991 M 47 868 M
EV / Sales 2020	7,50x
EV / Sales 2021	9,06x
Nbr of Employees	14 000
Free-Float	99,6%

More Financials

Company

Lonza Group is one of the world leaders of the development, production and marketing of chemical products. Net sales break down by family of products and services as follows: - bio-pharmaceuticals and nutritional ingredients (70.4%): exclusive syntheses, microbiological fermentation products , mammalian cell cultures, nutritional ingredients, etc. In addition, the group offers dosage solutions for...

Sector

Biotechnology & Medical Research

Calendar

03/03

Presentation

More about the company

Notations Surperformance© of Lonza Group AG

Trading Rating :

Investor Rating :

More Ratings

All news about LONZA GROUP AG

02/24	LONZA : is recognised by Ethisphere as One of the World's Most Ethical Companies..	AQ
02/23	LONZA : is recognised by Ethisphere ® as One of the World's Most Ethical Compani..	PU
02/16	LONZA : Expands Solid Form Selection Services at US Site	MT
02/16	PolyPeptide names new CEO before likely Swiss IPO during 2021	RE
02/16	LONZA : Expands Solid Form Services for Small Molecule Drugs	PU
02/16	LONZA : Deutsche Bank Lifts Price Target on Lonza Group, Maintains Buy Recommend..	MT
02/09	GLOBAL MARKETS LIVE: Still reeling from Tesla’s announcement
02/09	LONZA : Mirabaud Securities Lifts Price Target on Lonza Group, Maintains Buy Rec..	MT
02/09	LONZA : Inks $4.7 Billion Sale of Specialty Ingredients Unit to Private Equity D..	MT
02/09	Bain Capital, Cinven Buy Lonza's Specialty Ingredients Division	DJ
02/09	MARKET CHATTER : Eurazeo Plans Sale of $2.42 Billion Pharma Ingredients Business	MT
02/08	LONZA : Selling Specialty Ingredients Unit to Bain Capital, Cinven for $4.7 Bill..	MT
02/08	LONZA : Signs Agreement to Divest Specialty Ingredients Business to Bain Capital..	PU
02/08	REFILE-French pharma ingredients maker Seqens prepped for sale - sources	RE
02/04	South Korea in talks with Moderna over $200 million investment to build vacci..	RE

More news

News in other languages on LONZA GROUP AG

02/23	Aktien Schweiz mit Abschlägen - Credit Suisse fester
02/23	Ça tourne, action !
02/23	AVIS D'ANALYSTES DU JOUR : Adidas, Danone, Renault, Siemens, Lonza, Crédit Suiss..
02/22	Aktien Schweiz zu Wochenbeginn knapp behauptet
02/17	L'UE conclut un deuxième contrat avec Moderna pour 300 millions de doses

More news

Analyst Recommendations on LONZA GROUP AG

02/16	LONZA : Deutsche Bank Lifts Price Target on Lonza Group, Maintains Buy Recommend..	MT
02/09	LONZA : Mirabaud Securities Lifts Price Target on Lonza Group, Maintains Buy Rec..	MT
01/29	LONZA : Octavian Lifts Price Target on Lonza Group, Maintains Hold Recommendatio..	MT

More recommendations

Stock Trading Strategies

	LONZA GROUP AG - 2020
The stock is approaching a major resistance level

BUY

More Stock Trading Analysis

Provided by Scoopnest.com

Analysis

Moderna files for U.S. vaccine authorization, will seek EU nod